EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Circio Holding ASA's enterprise value is kr114.19 Mil.
Circio Holding ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr10.00 Mil. Therefore, Circio Holding ASA's EV-to-Revenue for today is 11.42.
The historical rank and industry rank for Circio Holding ASA's EV-to-Revenue or its related term are showing as below:
OSL:CRNA'
s EV-to-Revenue Range Over the Past 10 Years
Min: 8.11 Med: 4296.59 Max: 31743.4
Current: 11.42
During the past 12 years, the highest EV-to-Revenue of Circio Holding ASA was 31743.40. The lowest was 8.11. And the median was 4296.59.
OSL:CRNA's EV-to-Revenue is ranked worse than 58.7% of 1034
companies
in the Biotechnology industry
Industry Median: 7.85
vs OSL:CRNA: 11.42
The historical data trend for Circio Holding ASA's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Circio Holding ASA's EV-to-Revenue
For the Biotechnology subindustry, Circio Holding ASA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Circio Holding ASA's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Circio Holding ASA's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Circio Holding ASA's EV-to-Revenue falls into.
Circio Holding ASA's current Enterprise Value is kr114.19 Mil.
Circio Holding ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr10.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Circio Holding ASA's share price for today is kr2.57.
Circio Holding ASA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.59.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Circio Holding ASA EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Circio Holding ASA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Circio Holding ASA (OSL:CRNA) Business Description
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSL:CRNA has been successfully added to your 